- Home
- CDT vs STSS Comparison
CDT vs STSS Comparison
Compare CDT & STSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- STSS
- Stock Information
- Founded
- CDT 2019
- STSS 2017
- Country
- CDT United States
- STSS United States
- Employees
- CDT N/A
- STSS N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- STSS Medical/Dental Instruments
- Sector
- CDT Health Care
- STSS Health Care
- Exchange
- CDT Nasdaq
- STSS Nasdaq
- Market Cap
- CDT 5.2M
- STSS 5.8M
- IPO Year
- CDT N/A
- STSS 2022
- Fundamental
- Price
- CDT $1.93
- STSS $6.03
- Analyst Decision
- CDT
- STSS
- Analyst Count
- CDT 0
- STSS 0
- Target Price
- CDT N/A
- STSS N/A
- AVG Volume (30 Days)
- CDT 290.9K
- STSS 41.9K
- Earning Date
- CDT 08-11-2025
- STSS 08-13-2025
- Dividend Yield
- CDT N/A
- STSS N/A
- EPS Growth
- CDT N/A
- STSS N/A
- EPS
- CDT N/A
- STSS N/A
- Revenue
- CDT N/A
- STSS N/A
- Revenue This Year
- CDT N/A
- STSS N/A
- Revenue Next Year
- CDT N/A
- STSS N/A
- P/E Ratio
- CDT N/A
- STSS N/A
- Revenue Growth
- CDT N/A
- STSS N/A
- 52 Week Low
- CDT $1.90
- STSS $3.36
- 52 Week High
- CDT $622.50
- STSS $2,145.00
- Technical
- Relative Strength Index (RSI)
- CDT 28.61
- STSS 50.90
- Support Level
- CDT $1.94
- STSS $6.02
- Resistance Level
- CDT $2.31
- STSS $6.36
- Average True Range (ATR)
- CDT 0.16
- STSS 0.29
- MACD
- CDT 0.04
- STSS 0.07
- Stochastic Oscillator
- CDT 7.02
- STSS 48.15
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About STSS Sharps Technology Inc.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.